In your state
District of Columbia

In the development of new medicines, clinical trials are conducted to prove therapeutic safety and effectiveness and compile the evidence needed for the Food and Drug Administration (FDA) to approve treatments. And the biopharmaceutical sector is committed to bringing new treatments and cures to patients. This commitment to innovation supports high-quality jobs and is a vital part of every state’s economy and our global economic competitiveness.

Economic Impact In Your State: District of Columbia

$2.8B

Total output supported by biopharmaceutical sector

$186.6M

Tax Revenue Generated

8,359

Total Jobs

3,809

Direct Jobs

Clinical Trials in Your State: District of Columbia

294

TOTAL CLINICAL TRIALS

$63.3 million

INVESTED IN CLINICAL TRIALS

4,433

TOTAL ECONOMIC IMPACT OF CLINICAL TRIAL INVESTMENTS

$106.9 million

INVESTED IN CLINICAL TRIALS

Programs and Initiatives in Your State: District of Columbia


State programs and initiatives to promote biopharmaceutical industry development

This website uses cookies and other tracking technologies to optimize performance, preferences, usage, and statistics. By clicking “Accept All”, you consent to store on your device the cookies and other tracking technologies that require consent. You can tailor or change your preferences by clicking “Manage My Cookies”. You can check our privacy policy for more information.